REACH analysis shows benefits outweigh costs

Helsinki – An analysis by the European Chemicals Agency (ECHA) has found that the benefits of authorising hazardous chemicals under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation outweigh costs by 15 to one.

The report, ‘Socio-economic impacts of REACH authorisations’, calculates that €281 million of health risks arise each year from the continued use of chemicals that require authorisation, but that costs would be around €4.2 billion if the REACH system were not in place.

ECHA’s report was intended to look into the costs of the continued use of 20 substances of very high concern (SVHCs), finding that although risks remain high, authorisation has considerably reduced harm to the environment and individuals. The authorisation requirements for SVHCs have led to many companies substituting them with safer alternatives.

Discover new solutions and inspiring policy sessions on challenges and opportunities for sustainable aquaculture production and consumption in the European…

Read Story

On 13 September Ursula von der Leyen, President of the European Commission, gave her annual State of the Union address,…

Read Story

Eleven partners from four different European countries will work together to foster the access to market of bio-waste derived soil…

Read Story
Arrow-up